These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


184 related items for PubMed ID: 17699274

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The case against calcium-based phosphate binders.
    Moe SM, Chertow GM.
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):697-703. PubMed ID: 17699275
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Calcium-based phosphate binders; down, but not out.
    Elder GJ.
    Nephrol Dial Transplant; 2017 Jan 01; 32(1):5-8. PubMed ID: 28391312
    [No Abstract] [Full Text] [Related]

  • 5. [Disorders of calcium and phosphorus metabolism in renal failure and nephrotic syndrome].
    Kubota M, Ohno T.
    Nihon Rinsho; 1982 Jan 01; 40(12):2673-9. PubMed ID: 6761460
    [No Abstract] [Full Text] [Related]

  • 6. Phosphate binders in chronic kidney disease and end-stage renal disease: a patient-centered approach.
    Novak JE, Szczech LA.
    Semin Dial; 2009 Jan 01; 22(1):56-63. PubMed ID: 19000107
    [Abstract] [Full Text] [Related]

  • 7. [Phosphorus-calcium metabolism and dietetic correction of its disorders in chronic kidney diseases in children].
    Ladodo KS, Spirichev VB, Kisteneva GS, Blazheevich NV, Kutafina EK.
    Vopr Pitan; 1988 Jan 01; (1):24-8. PubMed ID: 3363911
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Magnesium carbonate is an effective phosphate binder for chronic hemodialysis patients: a pilot study.
    Spiegel DM, Farmer B, Smits G, Chonchol M.
    J Ren Nutr; 2007 Nov 01; 17(6):416-22. PubMed ID: 17971314
    [Abstract] [Full Text] [Related]

  • 10. Phosphate binders in a European haemodialysis population.
    Jean G, Vanel T.
    Nephrol Dial Transplant; 2011 Jun 01; 26(6):2057-8; author reply 2058. PubMed ID: 21414974
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical effect of introduction of sevelamer hydrochloride in patients with hyperphosphatemia undergoing maintenance dialysis].
    Tahara H, Tsujimoto Y, Shouji T, Inaba M, Tabata T, Nishizawa Y.
    Clin Calcium; 2005 Sep 01; 15 Suppl 1():173-9. PubMed ID: 16279021
    [No Abstract] [Full Text] [Related]

  • 13. Association of disorders in mineral metabolism with progression of chronic kidney disease.
    Schwarz S, Trivedi BK, Kalantar-Zadeh K, Kovesdy CP.
    Clin J Am Soc Nephrol; 2006 Jul 01; 1(4):825-31. PubMed ID: 17699293
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Disorders of calcium and phosphorus metabolism in rheumatoid arthritis].
    Ota K, Uezu A.
    Nihon Rinsho; 1982 Jul 01; 40(12):2729-37. PubMed ID: 6761466
    [No Abstract] [Full Text] [Related]

  • 16. The role of magnesium binders in chronic kidney disease.
    Spiegel DM.
    Semin Dial; 2007 Jul 01; 20(4):333-6. PubMed ID: 17635824
    [Abstract] [Full Text] [Related]

  • 17. All research does not a guideline make!
    Moorthi RN, Moe SM, Drüeke T, Uhlig K.
    Am J Kidney Dis; 2010 Apr 01; 55(4):631-4. PubMed ID: 20338464
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Phosphorus and calcium metabolism and the cardiovascular system status in patients with early-stage chronic renal disease].
    Smirnov AV, Volkov MM, Dobronravov VA, Rafrafi H.
    Ter Arkh; 2010 Apr 01; 82(6):25-8. PubMed ID: 20731105
    [Abstract] [Full Text] [Related]

  • 20. [A new phosphate management allows the control of vascular calcification in hemodialysis patients].
    Heitlinger E.
    Rev Med Suisse Romande; 2004 Nov 01; 124(11):2 p following 691. PubMed ID: 15631167
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.